Since life science quality and validation projects can vary widely in scope and complexity, each specific project needs to be evaluated in order to determine the...

The pharmaceutical industry is under unprecedented pressure. Shorter product lifecycles, increasingly complex therapies, stricter regulatory scrutiny and fragile...

2025 was a tumultuous year, riven with the consequences of global political instability, notably the looming threat, and implementation of, tariffs, alongside a ...

Pharmaceutical logistics has long been recognised as one of the most technically demanding areas of global supply chain management. Precision, credible temperatu...

The secure delivery of temperaturecontrolled shipments has evolved drastically in recent years, especially in regard to visibility that products are not compromi...

In Short: • The market for RSV therapies could grow to $7.2 billion by 2030. • There were 218 drugs in development for the treatment of RSV in November 2...

The inhalation industry is evolving. Advances in in silico and AI-based technologies, sustainability drivers, and a changing regulatory landscape are collectivel...

Spray Pattern (SP) and Plume Geometry (PG) testing have long been part of U.S. regulatory expectations. They are now explicitly addressed in the 2026 revision of...

Interest in the next generation of AI is rising in the pharma industry. In this sector-specific guide, ArisGlobal’s Jason Bryant assesses agentic AI’s promise and so...

The European Health Technology Assessment (HTA) landscape has long been characterised by heterogeneity in the clinical evaluation of health technologies after th...